{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:15:49Z","timestamp":1783707349904,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T00:00:00Z","timestamp":1407974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s11934-014-0444-z","type":"journal-article","created":{"date-parts":[[2014,8,13]],"date-time":"2014-08-13T13:57:55Z","timestamp":1407938275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The Evaluation and Management of Refractory Neurogenic Overactive Bladder"],"prefix":"10.1007","volume":"15","author":[{"given":"Raj","family":"Kurpad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Kennelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,14]]},"reference":[{"issue":"Suppl.","key":"444_CR1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.urology.2003.09.050","volume":"62","author":"P Abrams","year":"2003","unstructured":"Abrams P. Describing bladder storage function: overactive bladder syndrome and detrusor over-activity. Urology. 2003;62(Suppl):28. An excellent review of the pathophysiology of micturition. Additionally, this article provides an informative overview of overactive bladder.","journal-title":"Urology"},{"key":"444_CR2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M, et al. The standardization of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:167.","journal-title":"Neurourol Urodyn"},{"key":"444_CR3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/nau.20870","volume":"29","author":"P Abrams","year":"2010","unstructured":"Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C, et al. Fourth International consultation on incontinence recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010;29:213\u201340.","journal-title":"Neurourol Urodyn"},{"key":"444_CR4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1742-1241.2006.01182.x","volume":"60","author":"F Cruz","year":"2006","unstructured":"Cruz F, Siva C. Refractory neurogenic detrusor overactivity. Int J Clin Pract. 2006;60:22\u20135.","journal-title":"Int J Clin Pract"},{"key":"444_CR5","first-page":"2011","volume-title":"Campbell-Walsh urology","author":"AJ Wein","year":"2007","unstructured":"Wein AJ. Lower urinary tract dysfunction in neurologic injury and disease. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 9th ed. New York: Saunders; 2007. p. 2011\u201345. The definitive standard and authority on defining, detailing, and presenting the evaluation and management of neurogenic bladder.","edition":"9"},{"issue":"5","key":"444_CR6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1179\/2045772313Y.0000000106","volume":"36","author":"TA Linsenmeyer","year":"2013","unstructured":"Linsenmeyer TA, Linsenmeyer MA. Impact of annual urodynamic evaluations on guiding bladder management in individuals with spinal cord injuries. J Spinal Cord Med. 2013;36(5):420\u20136.","journal-title":"J Spinal Cord Med"},{"issue":"12","key":"444_CR7","first-page":"1359","volume":"4","author":"FJ Larijani","year":"2013","unstructured":"Larijani FJ, Moghtaderi M, Hajizadeh N, Assadi F. Preventing kidney injury in children with neurogenic bladder dysfunction. Int J Prev Med. 2013;4(12):1359\u201364.","journal-title":"Int J Prev Med"},{"issue":"3","key":"444_CR8","first-page":"182","volume":"10","author":"MJ Kennelly","year":"2008","unstructured":"Kennelly MJ, Devoe WB. Overactive bladder: pharmacologic treatments in the neurogenic population. Rev Urol. 2008;10(3):182\u201391. An excellent overview of the medical therapies available for the treatment of neurogenic detrusor overactivity. The authors also offer a broad outline of additional further therapies.","journal-title":"Rev Urol"},{"issue":"6","key":"444_CR9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s11934-011-0221-1","volume":"12","author":"A Sahai","year":"2011","unstructured":"Sahai A, Cortes E, Seth J, Khan MS, Panicker J, Kelleher C, et al. Neurogenic detrusor overactivity in patients with spinal cord injury: evaluation and management. Curr Urol Rep. 2011;12(6):404\u201312.","journal-title":"Curr Urol Rep"},{"issue":"1","key":"444_CR10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/jama.2010.1937","volume":"305","author":"A Albanese","year":"2011","unstructured":"Albanese A. Terminology for preparations of botulinum neurotoxins: what a difference a name makes. JAMA. 2011;305(1):89\u201390.","journal-title":"JAMA"},{"issue":"5","key":"444_CR11","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1179\/2045772313Y.0000000116","volume":"36","author":"TA Linsenmeyer","year":"2013","unstructured":"Linsenmeyer TA. Use of botulinum toxin in individuals with neurogenic detrusor overactivity: state of the art review. J Spinal Cord Med. 2013;36(5):402\u201319. A state-of-the-art review that provides excellent insight into the mechanism of action, as well as a review of the most current evidence available to support the use of botulinum toxin in the management of refractory neurogenic bladder.","journal-title":"J Spinal Cord Med"},{"issue":"5","key":"444_CR12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","volume":"47","author":"J Grosse","year":"2005","unstructured":"Grosse J, Kramer G, St\u00f6hrer M. Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol. 2005;47(5):653\u20139.","journal-title":"Eur Urol"},{"issue":"3 Pt 1","key":"444_CR13","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"B Schurch","year":"2000","unstructured":"Schurch B, St\u00f6hrer M, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol. 2000;164(3 Pt 1):692\u20137.","journal-title":"J Urol"},{"issue":"3","key":"444_CR14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.eururo.2007.08.039","volume":"53","author":"X Gam\u00e9","year":"2008","unstructured":"Gam\u00e9 X, Castel-Lacanal E, Bentaleb Y, Thiry-Escudi\u00e9 I, DeBoissezon X, Malavaud B, et al. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of urinary tract infections. Eur Urol. 2008;53(3):613\u20138.","journal-title":"Eur Urol"},{"issue":"3","key":"444_CR15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2008.08.048","volume":"55","author":"A Giannantoni","year":"2009","unstructured":"Giannantoni A, Mearini E, Del Zingaro M, Porena M. Six-year follow-up of botulinum toxin A intradetrusotial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results. Eur Urol. 2009;55(3):705\u201311.","journal-title":"Eur Urol"},{"issue":"4","key":"444_CR16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.clinthera.2013.02.020","volume":"35","author":"JJ Carlson","year":"2013","unstructured":"Carlson JJ, Hansen RN, Dmochowski RR, Globe DR, Colayco DC, Sullivan SD. Estimating the cost-effectiveness of onabotulinumtoxinA for neurogenic detrusor overactivity in the United States. Clin Ther. 2013;35(4):414\u201324.","journal-title":"Clin Ther"},{"issue":"3","key":"444_CR17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.urology.2012.11.010","volume":"81","author":"M Kennelly","year":"2013","unstructured":"Kennelly M, Dmochowski R, Ethans K, et al. Long-term efficacy and safety of onabotulinum toxin A in patients with urinary incontinence due to neurogenicdetrusor overactivity: an interim analysis. Urology. 2013;81(3):491\u20137.","journal-title":"Urology"},{"issue":"1","key":"444_CR18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.urology.2013.09.017","volume":"83","author":"RU Anderson","year":"2014","unstructured":"Anderson RU, Orenberg EK, Glowe P. Onabotulinum toxin A office treatment for neurogenic bladder incontinence in Parkinson's disease. Urology. 2014;83(1):22\u20137.","journal-title":"Urology"},{"issue":"9","key":"444_CR19","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1212\/WNL.0b013e3182a2ca4d","volume":"81","author":"MB Chancellor","year":"2013","unstructured":"Chancellor MB, Patel V, Leng WW, Shenot PJ, Lam W, Globe DR, et al. OnabotulinumtoxinA improves quality of life in patients with neurogenic detrusor overactivity. Neurology. 2013;81(9):841\u20138.","journal-title":"Neurology"},{"issue":"3","key":"444_CR20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/nau.22293","volume":"32","author":"D Sussman","year":"2013","unstructured":"Sussman D, Patel V, Del Popolo G, Lam W, Globe D, Pommerville P. Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity. Neurourol Urodyn. 2013;32(3):242\u20139.","journal-title":"Neurourol Urodyn"},{"key":"444_CR21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/acrefore\/9780199975839.013.137","volume-title":"Electrotherapy: evidence-based practice","author":"M Johnson","year":"2008","unstructured":"Johnson M. Transcutaneous electrical nerve stimulation. In: Watson T, editor. Electrotherapy: evidence-based practice. Edinburgh: Churchill Livingstone; 2008. p. 253\u201396."},{"issue":"1","key":"444_CR22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1525-1403.2000.00015.x","volume":"3","author":"MB Chancellor","year":"2000","unstructured":"Chancellor MB, Chartier-Kastler EJ. Neuromodulation. 2000;3(1):16\u201326.","journal-title":"Neuromodulation"},{"key":"444_CR23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ucl.2006.06.009","volume":"33","author":"WW Leng","year":"2006","unstructured":"Leng WW, Morrisroe SN. Urol Clin N Am. 2006;33:491\u2013501.","journal-title":"Urol Clin N Am"},{"key":"444_CR24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.urology.2005.04.031","volume":"66","author":"CL Amundsen","year":"2005","unstructured":"Amundsen CL, Romero AA, Jamison MG, Webster GD. Sacral neuromodulation for intractable urge incontinence: are there factors associated with cure? Urology. 2005;66:746\u201350.","journal-title":"Urology"},{"key":"444_CR25","unstructured":"Medtronic. MRI guidelines for InterStimTherapy neurostimulation systems [online], http:\/\/manuals.medtronic.com\/wcm\/groups\/mdtcom_sg\/@emanuals\/@era\/@neuro\/documents\/documents\/contrib_119885.pdf (2012)."},{"issue":"9","key":"444_CR26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrurol.2013.143","volume":"10","author":"J Bartley","year":"2013","unstructured":"Bartley J, Gilleran J, Peters K. Neuromodulation for overactive bladder. Nat Rev Urol. 2013;10(9):513\u201321. doi: 10.1038\/nrurol.2013.143 . A detailed review of the mechanism of action and a review of the current literature regarding the various modalities of neuromodulation that may be used in the management of refractory neurogenic bladder.","journal-title":"Nat Rev Urol"},{"issue":"4","key":"444_CR27","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.urology.2012.11.073","volume":"81","author":"KM Peters","year":"2013","unstructured":"Peters KM, Kandagatla P, Killinger KA, Wolfert C, Boura JA. Clinical outcomes of sacral neuromodulation in patients with neurologic conditions. Urology. 2013;81(4):738\u201343.","journal-title":"Urology"},{"issue":"3","key":"444_CR28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sc.2013.155","volume":"52","author":"G Lombardi","year":"2014","unstructured":"Lombardi G, Musco S, Celso M, Del Corso F, Del Popolo G. Sacral neuromodulation for neurogenic non-obstructive urinary retention in incomplete spinal cord patients: a ten-year follow-up single-centre experience. Spinal Cord. 2014;52(3):241\u20135.","journal-title":"Spinal Cord"},{"key":"444_CR29","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1097\/01.ju.0000067446.17576.bd","volume":"169","author":"G Amarenco","year":"2003","unstructured":"Amarenco G et al. Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder. J Urol. 2003;169:2210\u20135.","journal-title":"J Urol"},{"issue":"3","key":"444_CR30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.juro.2013.09.036","volume":"191","author":"C Zecca","year":"2014","unstructured":"Zecca C, Digesu GA, Robshaw P, Singh A, Elneil S, Gobbi C. Maintenance percutaneous posterior nerve stimulation for refractory lower urinary tract symptoms in patients with multiple sclerosis: an open label, multicenter, prospective study. J Urol. 2014;191(3):697\u2013702.","journal-title":"J Urol"},{"issue":"5","key":"444_CR31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11934-012-0271-z","volume":"13","author":"KP Sajadi","year":"2012","unstructured":"Sajadi KP, Goldman HB. Bladder augmentation and urinary diversion for neurogenic LUTS: current indications. Curr Urol Rep. 2012;13(5):389\u201393. An overview of the many types of urinary augmentation and diversion surgeries, their indications, and their techniques.","journal-title":"Curr Urol Rep"},{"key":"444_CR32","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1464-410X.2011.10650.x","volume":"109","author":"SB Biers","year":"2011","unstructured":"Biers SB, Venn SN, Greenwell TJ. The past, present and future of augmentation cystoplasty. BJUI. 2011;109:1280\u201393.","journal-title":"BJUI"},{"key":"444_CR33","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1464-410X.2011.10509.x","volume":"109","author":"Gurung","year":"2012","unstructured":"Gurung, Attar KH, Abdul-Rahman A, et al. Long-term outcomes of augmentation ileocystoplasty in patients with spinal cord injury: a minimum of 10\u00a0years of follow-up. BJU Int. 2012;109:1236\u201342.","journal-title":"BJU Int"},{"key":"444_CR34","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0090-4295(03)00580-6","volume":"62","author":"P Vaida","year":"2003","unstructured":"Vaida P, Pinter AB, Harangi F, et al. Metabolic findings after colocystoplasty in children. Urology. 2003;62:542\u20136.","journal-title":"Urology"},{"issue":"4","key":"444_CR35","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00120-012-2815-8","volume":"51","author":"T K\u00e4lble","year":"2012","unstructured":"K\u00e4lble T, Hofmann I, Th\u00fcroff JW, et al. Secondary malignancies in urinary diversions. Urologe A. 2012;51(4):500. 502-6.","journal-title":"Urologe A"},{"issue":"2","key":"444_CR36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.18553\/jmcp.2014.20.2.130","volume":"20","author":"KS Coyne","year":"2014","unstructured":"Coyne KS, Wein A, Nicholson S, Kvasz M, Chen CI, Milsom I. Economic burden of urgency urinary incontinence in the United States: a systematic review. J Manag Care Pharm. 2014;20(2):130\u201340.","journal-title":"J Manag Care Pharm"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-014-0444-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-014-0444-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-014-0444-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T10:36:29Z","timestamp":1649932589000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-014-0444-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,14]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["444"],"URL":"https:\/\/doi.org\/10.1007\/s11934-014-0444-z","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,14]]},"article-number":"444"}}